Home/MediciNova/Carolyn Beaver
CB

Carolyn Beaver

Member of the Board of Directors

MediciNova

MediciNova Pipeline

DrugIndicationPhase
MN-166 (ibudilast)Progressive Multiple SclerosisPhase 3
MN-221Acute Exacerbations of AsthmaPhase 3
MN-001Liver Fibrosis (NASH)Phase 2
MN-029Oncology (unspecified)Not Disclosed
MN-305Not specifiedNot Disclosed
MN-246Not specifiedNot Disclosed
Portfolio CandidateSolid Tumor CancersPreclinical/Clinical